ELOS Syneron Medical Ltd. - Ordinary Shares

Syneron Medical Schedules 2004 Second Quarter Earnings Release and Conference Call YOKNEAM, ISRAEL and TORONTO, CANADA, Aug. 16 /PRNewswire-FirstCall/ -- Syneron Medical Ltd. (NASDAQ:ELOS), an innovator in the development and distribution of ELOS combined-energy medical aesthetic devices, will announce its 2004 second quarter results, for the period ended June 30, 2004, on Wednesday, August 18, 2004. Management of Syneron will hold a conference call that morning at 10:00 a.m. ET to discuss the results for the quarter. To participate in the call, please dial: Toll Free North America - 800-387-6216, (416-405-9328 for international callers) at least five minutes prior to the start time. Investors will also have the opportunity to listen to the conference call live on the Internet through Syneron's website at http://www.syneron.com/. Investors should go to the website a few minutes early, as it may be necessary to download audio software to access the conference call. A replay of the call will be available through Syneron's website, http://www.syneron.com/. About Syneron Syneron Medical Ltd. manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented ELOS combined-energy technology of Bi-Polar Radio Frequency and Light. The Company's innovative ELOS technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world including sales, service and support subsidiaries located in Toronto, Canada (Syneron Inc.) and Grunwald, Germany (Syneron GmbH). Please visit http://www.syneron.com/. Syneron, the Syneron logo and ELOS are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. ELOS (Electro-Optical Synergy) is a proprietary technology of Syneron Medical Ltd. All other names are the property of their respective owners. DATASOURCE: Syneron Medical Ltd. CONTACT: Moshe Mizrahy, CEO of Syneron Medical Ltd., at +972 4 909-7424, email: , or Domenic Serafino, President of Syneron Inc., at (866) 259-6661 ext. 247, email: ; Syneron Medical Ltd., Industrial Zone, Yokneam Illit, 20692, P.O.B. 550 Israel, Tel: +972 4 909-7424, Fax: +972 4 909-7417, ; Syneron Inc., 111 Granton Drive, Richmond Hill, Ontario L4B 1L5 Canada, Tel: (905) 886-9235, Fax: (905) 886-7046, Toll Free: 1-866-259-6661,

Copyright